Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414268 · ClinicalTrials.gov registry record · Phase 3
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
A Phase 3 study, sponsored by MiMedx Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 208
- Enrollment target
NCT03414268: Completed Phase 3 study, sponsored by MiMedx Group.
NCT03414268 is a Phase 3 study that has completed, run by MiMedx Group. The registered enrollment target is 208 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03414268, a Phase 3 study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 208 participants
- Enrollment target
Study Summary
Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as compared to the saline placebo injection in the treatment of plantar fasciitis
Primary Outcome
Visual Analog Scale for Pain:
Interventions
- DRUG Saline Injection
- OTHER Micronized dHACM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2021-03-17 |
| Phase | Phase 3 |
What the finished NCT03414268 record still lists
NCT03414268 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline Injection is the first listed.
NCT03414268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03414268 about?
NCT03414268 is a clinical study titled "Micronized dHACM Injectable for the Treatment of Plantar Fasciitis". Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as compared to the saline placebo injection in the treatment of plantar fasciitis
What is the current status of trial NCT03414268?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 208 participants. The study started on 2018-01-08. Estimated completion is 2021-03-17.
What interventions are being tested in trial NCT03414268?
The interventions under investigation include: Saline Injection (DRUG), Micronized dHACM (OTHER).
Who is sponsoring clinical trial NCT03414268?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03414268's enrollment target sits among peer trials
208 1345th of 2000 higher than 655 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI